Status:
UNKNOWN
The Prevalence of Sub Optimal Anti Coagulation
Lead Sponsor:
Assiut University
Conditions:
Poor Drug Response
Eligibility:
All Genders
Brief Summary
A study on warfarin administration to show whether noncompliance of the patient will affect our target (INR) during therapy or not beside its drug and dietary interactions. The study will show the pr...
Detailed Description
Besides the risk of infective endocarditis, thromboembolism from the foreign body structures of the prosthesis remains a major problem, which can be effectively reduced, but not inhibited by the use o...
Eligibility Criteria
Inclusion
- All patients of prosthetic cardiac valves undergo warfarin therapy with sub optimal anti coagulation
Exclusion
- Refusal of the patients
- Patients with target INR (2.5-3.5)
- Patients with hypoalbumenimia and chronic liver diseases
Key Trial Info
Start Date :
December 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03485300
Start Date
December 1 2018
End Date
December 1 2019
Last Update
July 3 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.